Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Oct;19(10):1673-1681.
doi: 10.1016/j.hrthm.2022.05.009. Epub 2022 May 11.

Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises

Affiliations
Multicenter Study

Cardiac crises: Cardiac arrhythmias and cardiomyopathy during TANGO2 deficiency related metabolic crises

Christina Y Miyake et al. Heart Rhythm. 2022 Oct.

Abstract

Background: TANGO2 deficiency disorder (TDD) is an autosomal recessive disease associated with metabolic crisis, lethal cardiac arrhythmias, and cardiomyopathy. Data regarding treatment, management, and outcomes of cardiac manifestations of TDD are lacking.

Objective: The purpose of this study was to describe TDD-related cardiac crises.

Methods: Retrospective multicenter chart review was made of TDD patients admitted with cardiac crises, defined as development of ventricular tachycardia (VT), cardiomyopathy, or cardiac arrest during metabolic crises.

Results: Twenty-seven children were admitted for 43 cardiac crises (median age 6.4 years; interquartile range [IQR] 2.4-9.8 years) at 14 centers. During crisis, QTc prolongation occurred in all (median 547 ms; IQR 504-600 ms) and a type I Brugada pattern in 8 (26%). Arrhythmias included VT in 21 (78%), supraventricular tachycardia in 3 (11%), and heart block in 1 (4%). Nineteen patients (70%) developed cardiomyopathy, and 20 (74%) experienced a cardiac arrest. There were 10 deaths (37%), 6 related to arrhythmias. In 5 patients, recalcitrant VT occurred despite use of antiarrhythmic drugs. In 6 patients, arrhythmias were controlled after extracorporeal membrane oxygenation (ECMO) support; 5 of these patients survived. Among 10 patients who survived VT without ECMO, successful treatment included intravenous magnesium, isoproterenol, and atrial pacing in multiple cases and verapamil in 1 patient. Initiation of feeds seemed to decrease VT events.

Conclusion: TDD-related cardiac crises are associated with a high risk of arrhythmias, cardiomyopathy, cardiac arrest, and death. Although further studies are needed, early recognition and appropriate treatment are critical. Acutely, intravenous magnesium, isoproterenol, atrial pacing, and ECMO as a last resort seem to be the best current treatment options, and early initiation of feeds may prevent VT events.

Keywords: Arrhythmia; Brugada syndrome; Cardiac arrest; Cardiomyopathy; Crisis; Death; Long QT syndrome; TANGO2; Treatment; Ventricular tachycardia.

PubMed Disclaimer

Conflict of interest statement

Disclosures: The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Electrocardiographic (ECG) changes during metabolic crises demonstrate both prolonged QTc and intermittent Brugada type I pattern. All ECGs are from the same subject (family 6, individual 9). A: Baseline ECG when not in crisis is normal, including QTc. B: During metabolic crisis, QTc is prolonged. No Brugada pattern is seen. C: During the same crisis, the ECG demonstrates both QTc prolongation and concurrent type I Brugada pattern. D: ECG captures frequent isolated ventricular ectopy and nonsustained polymorphic ventricular tachycardia (NSVT).
Figure 2
Figure 2
Typical progression of ventricular arrhythmias during cardiac crises. The telemetry strips are from the same subject (family 6, individual 9). Salvos of nonsustained and sustained polymorphic ventricular tachycardia. A: VT is slower, begin monormorphic and degenerates. B: Hemodynamically unstable torsade de pointes resulted in loss of consciousness.

Comment in

References

    1. Lalani SR, Liu P, Rosenfeld JA, et al. Recurrent muscle weakness with rhabdo- myolysis, metabolic crises, and cardiac arrhythmia due to bi-allelic TANGO2 mutations. Am J Hum Genet 2016;98:347–357. - PMC - PubMed
    1. Kremer LS, Distelmaier F, Alhaddad B, et al. Bi-allelic truncating mutations in TANGO2 cause infancy-onset recurrent metabolic crises with encephalocardio- myopathy. Am J Hum Genet 2016;98:358–362. - PMC - PubMed
    1. Berat CM, Montealegre S, Wiedemann A, et al. Clinical and biological characterization of 20 patients with TANGO2 deficiency indicates novel triggers of metabolic crises and no primary energetic defect. J Inherit Metab Dis 2021; 44:415–425. - PubMed
    1. Dines JN, Golden-Grant K, LaCroix A, et al. TANGO2: expanding the clinical phenotype and spectrum of pathogenic variants. Genet Med 2019; 21:601–607. - PMC - PubMed
    1. Jennions E, Hedberg-Oldfors C, Berglund AK, et al. TANGO2 deficiency as a cause of neurodevelopmental delay with indirect effects on mitochondrial energy metabolism. J Inherit Metab Dis 2019;42:898–908. - PubMed

Publication types